Remifentanil and Atropine for Intubation in Neonates (RAIN)
Remifentanil and Atropine for Intubation in Neonates; a Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8S 4J9
- McMaster University NICU
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Hemodynamically stable neonates of any gestational age admitted to the Neonatal Intensive Care Unit at McMaster Children's Hospital requiring an elective endotracheal intubation was anticipated.
Exclusion Criteria:
- Urgent intubations
- Cyanotic congenital heart lesions
- Anticipated difficult airway
- Concurrent or recently administered (within 3 hours of the procedure) intravenous opioid infusions
- Pre-existing hyperkalemia
- Family history of malignant hyperthermia
- Prior enrollment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Remifentanil
Atropine Remifentanil |
Atropine 20mcg/kg Remifentanil 3mcg/kg |
|
Placebo Comparator: Fentanyl
Atropine Fentanyl Succinylcholine |
Atropine 20mcg/kg Fentanyl 2mcg/kg Succinylcholine 2mg/kg |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Time to Successful intubation
Time Frame: 15 minutes
|
15 minutes
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Time to return of spontaneous respirations
Time Frame: 15 minutes
|
15 minutes
|
|
Oxygen saturation
Time Frame: During the procedure up to 15 minutes
|
During the procedure up to 15 minutes
|
|
Heart Rate
Time Frame: During the procedure up to 15 minutes
|
During the procedure up to 15 minutes
|
|
Blood Pressure
Time Frame: During the procedure up to 15 minutes
|
During the procedure up to 15 minutes
|
|
Intubation Condition
Time Frame: 15 minutes post procedure
|
15 minutes post procedure
|
|
Evidence of Trauma
Time Frame: 15 minutes post procedure
|
15 minutes post procedure
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Khalid M Alfaleh, MBBS, MSc, King Saud University
- Study Director: Karen Choong, FRCPC, McMaster University
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Parasympatholytics
- Autonomic Agents
- Peripheral Nervous System Agents
- Muscarinic Antagonists
- Cholinergic Antagonists
- Cholinergic Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Adjuvants, Anesthesia
- Bronchodilator Agents
- Anti-Asthmatic Agents
- Respiratory System Agents
- Neuromuscular Agents
- Mydriatics
- Neuromuscular Blocking Agents
- Neuromuscular Depolarizing Agents
- Remifentanil
- Fentanyl
- Atropine
- Succinylcholine
Other Study ID Numbers
Other Study ID Numbers
- RAIN
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.